Impact of COVID-19 on assisted reproductive technologies and its multifacet influence on global bioeconomy
1Department of Physiology, Laboratory for Reproductive Biology and Developmental Programming Edo University Iyamho, Auchi, Edo State, Nigeria
2Department of Microbiology, Laboratory for Reproductive Biology and Developmental Programming Edo University Iyamho, Auchi, Edo State, Nigeria
3Department of Physiology, University of Ibadan, Ibadan, Oyo State, Nigeria
4Department of Physiology, University of Medical Sciences, Ondo City, Nigeria
5Department of Biological Sciences, Laboratory of Ecotoxicology and Forensic Biology, Edo University Iyamho, Edo State, Nigeria
6Department of Zoology, University of Rajasthan Jaipur, Jaipur, Rajasthan, India
*Corresponding author: Olugbemi Tope Olaniyan, Laboratory for Reproductive Biology and Developmental Programming, Department of Physiology, Edo University Iyamho, Auchi, Edo State, Nigeria. email@example.com
© 2020 Published by Scientific Scholar on behalf of Journal of Reproductive Healthcare and Medicine
How to cite this article: Olaniyan OT, Adetunji CO, Okotie GE, Adeyomoye O, Anani OA, Mali PC. Impact of COVID-19 on assisted reproductive technologies and its multifacet influence on global bioeconomy. J Reprod Healthc Med 2021;2(Suppl_1):S92-S104.
Several nations of the world have issued instructions such as travel restrictions, border closure, and lockdown, plus other directives proposing that non-essential care must be withdrawn including assisted reproductive services, in an attempt to identify resources to ascertain the dissemination of SARS-CoV-2. This has led to massive shortage in medical supplies, inappropriate service delivery, hike in price, decrease in staff work load, salary cut, decrease in the utilization of qualitative maternal, and reproductive health-care services thereby creating high risk on reproductive health and global bioeconomy. The search for right candidate for the management of coronavirus disease 2019 and several reproductive health challenges begins with the screening of natural products to identify novel active constituent. Moreover, there is need to pay more attention to crucial phytochemical, bioactive fractions, phytoanalysis, and phytopharmacological investigation for effective drug discovery most especially these bioresources from beneficial microorganisms, plants, and ocean deposits that could help in mitigation of SARS-CoV-2 and reproduction health challenges through chemoinformatics, informatics, synthetic biology, nanotechnology, and metabolomics hence boosting the global economy.
Coronavirus disease 2019
Assisted reproductive technologies